In vivo study of the mutagenicity of biperidine, pipotiazine, chlorpromazine, and haloperidol
- Universidade Federal de Sao Paulo (Brazil)
The evaluation of the mutagenic potential of drugs during long-term psychiatric use in schizophrenic patients is of interest considering that the incidence and treatment of this disorder comes in the reproductive age and that there is a close correlation between mutagenic and carcinogenic compounds. We did a case-control study involving 12 patients with schizophrenia diagnosed by DMS III-R, of whom 6 were men and 6 women, with an average age of 33.25 years (s.d. {+-} 7.44) and 12 controls matched for sex and for the same age. This is the first case-controlled study comparing patients under treatment with biperidine, pipotiazine, chlorpromazine, and haloperidol with normal controls in relation to the frequency of chromosomal lesions. 4 refs.
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 447671
- Journal Information:
- American Journal of Medical Genetics, Vol. 67, Issue 2; Other Information: PBD: 9 Apr 1996
- Country of Publication:
- United States
- Language:
- English
Similar Records
Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia
Dopamine D{sub 3} receptor gene: Organization transcript variants, and polymorphism associated with schizophrenia